checkAd
    Startseite > Aktien > Equillium > Nachrichten
    Equillium Aktie
    1,4120
     
    EUR
    -8,07 %
    -0,1240 EUR
    Letzter Kurs 30.04.24 Tradegate
    1,2960
     
    EUR
    2.315 STK
    Geldkurs 10:35:10
    1,4300
     
    EUR
    2.095 STK
    Briefkurs 10:35:10
    ISIN: US29446K1060 · WKN: A2N7B3 · SYM: 0FY · USA

    Neueste Nachrichten

    Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    03.04.24 · Business Wire (engl.) · Equillium
    Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
    01.04.24 · Business Wire (engl.) · Equillium
    Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
    25.03.24 · Business Wire (engl.) · Equillium
    Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference
    22.03.24 · Business Wire (engl.) · Equillium
    Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease
    21.12.23 · Business Wire (engl.) · Equillium
    Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
    13.11.23 · Business Wire (engl.) · Equillium
    Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
    08.11.23 · Business Wire (engl.) · Equillium
    Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
    06.11.23 · Business Wire (engl.) · Equillium
    Equillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of Rheumatology
    19.10.23 · Business Wire (engl.) · Equillium
    Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium
    16.10.23 · Business Wire (engl.) · Equillium
    Equillium to Host Analyst & Investor Day
    03.10.23 · Business Wire (engl.) · Equillium
    Equillium to Present at the JonesTrading 2023 Healthcare Summit
    02.10.23 · Business Wire (engl.) · Equillium